000 03184nam a22005295i 4500
001 978-981-10-0063-8
003 DE-He213
005 20200421111157.0
007 cr nn 008mamaa
008 160111s2016 si | s |||| 0|eng d
020 _a9789811000638
_9978-981-10-0063-8
024 7 _a10.1007/978-981-10-0063-8
_2doi
050 4 _aR856-857
072 7 _aMQW
_2bicssc
072 7 _aTEC009000
_2bisacsh
082 0 4 _a610.28
_223
245 1 0 _aAdvances in Nanotheranostics II
_h[electronic resource] :
_bCancer Theranostic Nanomedicine /
_cedited by Zhifei Dai.
264 1 _aSingapore :
_bSpringer Singapore :
_bImprint: Springer,
_c2016.
300 _aXI, 381 p. 158 illus., 141 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aSpringer Series in Biomaterials Science and Engineering,
_x2195-0644 ;
_v7
520 _aThis book surveys recent advances in theranostics based on magnetic nanoparticles, ultrasound contrast agents, silica nanoparticles and polymeric micelles. It presents magnetic nanoparticles, which offer a robust tool for contrast enhanced MRI imaging, magnetic targeting, controlled drug delivery, molecular imaging guided gene therapy, magnetic hyperthermia, and controlling cell fate. Multifunctional ultrasound contrast agents have great potential in ultrasound molecular imaging, multimodal imaging, drug/gene delivery, and integrated diagnostics and therapeutics. Due to their diversity and multifunctionality, polymeric micelles and silica-based nanocomposites are highly capable of enhancing the efficacy of multimodal imaging and synergistic cancer therapy. This comprehensive book summarizes the main advances in multifunctional nanoprobes for targeted imaging and therapy of gastric cancer, and explores the clinical translational prospects and challenges. Although more research is needed to overcome the substantial obstacles that impede the development and availability of nanotheranostic products, such nontrivial nanoagents are expected to revolutionize medical treatments and help to realize the potential of personalized medicine to diagnose, treat, and follow-up patients with cancer. Zhifei Dai is a Professor at the Department of Biomedical Engineering, College of Engineering, Peking University, China.
650 0 _aEngineering.
650 0 _aRadiology.
650 0 _aOncology.
650 0 _aBiomedical engineering.
650 0 _aBiomaterials.
650 0 _aNanotechnology.
650 1 4 _aEngineering.
650 2 4 _aBiomedical Engineering.
650 2 4 _aNanotechnology.
650 2 4 _aImaging / Radiology.
650 2 4 _aBiomaterials.
650 2 4 _aOncology.
700 1 _aDai, Zhifei.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789811000614
830 0 _aSpringer Series in Biomaterials Science and Engineering,
_x2195-0644 ;
_v7
856 4 0 _uhttp://dx.doi.org/10.1007/978-981-10-0063-8
912 _aZDB-2-ENG
942 _cEBK
999 _c53578
_d53578